CareLit · DOI-Nachweis · Pneumologie
Florensocatib, an inhibitor of dipeptidyl peptidase-1, for the treatment of non-cystic fibrosis bronchiectasis: Rationale and Design of the FABLE Phase III trial
DOI 10.1055/s-0046-1826149
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ D Chalmers, F C Ringshausen, P Iveli, T Arslan, N Baririan, S Biondaro, S Druelles, G Giorli, S Grant, B Guidoux, R Macchia, D MacLennan, F Zuccaro, L Labadini
ZeitschriftPneumologie
Ausgabe10/2026
Jahrgang / SeitenJg. 80 · S. e68
Kernaussage aus der Literatur
Abstract-Vorschau
Florensocatib, an inhibitor of dipeptidyl peptidase-1, for the treatment of non-cystic fibrosis bronchiectasis: Rationale and Design of the FABLE Phase III trial
Zitieren
Zitierempfehlung
J D Chalmers, F C Ringshausen, P Iveli, T Arslan, N Baririan, S Biondaro, S Druelles, G Giorli, S Grant, B Guidoux, R Macchia, D MacLennan, F Zuccaro, L Labadini (2026) Florensocatib, an inhibitor of dipeptidyl peptidase-1, for the treatment of non-cystic fibrosis bronchiectasis: Rationale and Design of the FABLE Phase III trial. Pneumologie, 80 (10), e68. https://doi.org/10.1055/s-0046-1826149
Mit CareLit weiterarbeiten